دورية أكاديمية

Glucose Lowering Effect of SGLT2 Inhibitors: A Review of Clinical Studies ; SGLT2 억제제의 혈당 강하 효과

التفاصيل البيبلوغرافية
العنوان: Glucose Lowering Effect of SGLT2 Inhibitors: A Review of Clinical Studies ; SGLT2 억제제의 혈당 강하 효과
المؤلفون: Kim, HJ
المساهمون: 105743, 김, 혜진
سنة النشر: 2014
مصطلحات موضوعية: Hypoglycemic agents, Sodium glucose cotransporter 2, Type 2 diabetes mellitus
الوصف: There are numerous glucose lowering agents in clinical use for type 2 diabetic patients, yet most do not achieve glycemic targets. Recently, inhibitors of the sodium glucose cotransporter 2 (SGLT2) have been developed, which show great potential of being a novel therapeutic option to treat type 2 diabetes. Many researches have turned their attention to the kidney as a target because renal glucose reabsorption is increased in type 2 DM. SGLT2 is a protein transporter that mediates glucose reabsorption from glomerular filtrates. In an insulinindependent manner, inhibition of SGLT2 increases urinary glucose excretion and decreases plasma glucose levels. To date, there are a few SGLT2 inhibiting agents being clinically studied both as a monotherapy and in combination with other antidiabetic agents. This review will focus on the efficacy of SGLT2 inhibitors based on clinical studies.
نوع الوثيقة: article in journal/newspaper
اللغة: Korean
تدمد: 2233-7431
العلاقة: J022337431; http://repository.ajou.ac.kr/handle/201003/11482Test; https://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2014.15.3.146Test; The Journal of Korean Diabetes, 15(3). : 146-150, 2014
DOI: 10.4093/jkd.2014.15.3.146
الإتاحة: https://doi.org/10.4093/jkd.2014.15.3.146Test
http://repository.ajou.ac.kr/handle/201003/11482Test
رقم الانضمام: edsbas.11CE30B9
قاعدة البيانات: BASE
الوصف
تدمد:22337431
DOI:10.4093/jkd.2014.15.3.146